Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles

Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice
                President; Announces Retirement of Anne Nobles

PR Newswire

INDIANAPOLIS, Oct. 30, 2012

INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY)
today announced that Melissa Barnes will be promoted to chief ethics and
compliance officer and senior vice president of enterprise risk management
effective Jan. 1, 2013. Barnes will replace Anne Nobles, who will retire at
the end of the year.

Barnes, vice president and deputy general counsel, is currently responsible
for litigation, compliance and specialty legal areas, including regulatory and
human resources.In her new role, Barnes will report to John Lechleiter,
Ph.D., chairman, president and CEO, and will serve on the company's executive
committee.

"Melissa's legal background and extensive experience at Lilly make her the
right person to assume this important role within our company," said
Lechleiter. "Lilly is committed to conducting our business with the highest
level of integrity and in full compliance with the laws and regulations that
govern our operations. Having someone with Melissa's qualifications lead our
ethics and compliance organization is evidence of this commitment." 

Barnes is a graduate of Harvard Law School. She joined the company in 1994 and
has served in a number of legal and business positions at Lilly, specializing
in legal work related to compliance, litigation, human resources, regulatory,
business management strategy, and global marketing and sales.

Nobles joined Lilly in 1990 and has served in various leadership positions,
including vice president of corporate affairs. She became Lilly's chief
compliance officer in 2007 and has served on the company's executive committee
since 2009.

"Anne has provided critical leadership at a very important time for our
company," said Lechleiter. "Her contributions have been instrumental in
building a comprehensive company-wide ethics and compliance program. She has
worked closely with Lilly business leaders to ensure that compliance is
effectively integrated into our business plans and our day-to-day activities."

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers-
through medicines and information- for some of the world's most urgent
medical needs. Additional information about Lilly is available at
www.lilly.com.C-LLY

(Photo: http://photos.prnewswire.com/prnh/20121030/DE01944)

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)

SOURCE Eli Lilly and Company

Website: http://www.lilly.com
Contact: Janice Chavers,+1-317-651-6253, chavers_janice_m@lilly.com
 
Press spacebar to pause and continue. Press esc to stop.